Listen

Description

全球约2.8亿人受心脏瓣膜问题困扰,药物无效只能手术,现有替换方案有缺陷。科学家用干细胞构建出带功能性瓣膜的三维心脏类器官,为研究瓣膜发育、病变及药物测试提供新模型,有望推动个性化治疗和再生瓣膜研发。

参考文献:

  1. He Y et al. (Li G, 通讯作者). Human iPSC-derived heart valve-like assembloids model valve development and disease pathology. Cell Stem Cell. 2026-08-11. DOI: 10.1016/j.stem.2026.07.011. https://www.cell.com/cell-stem-cell/fulltext/S1934-5909(26)00271-7

  2. Voges HK et al. Human heart valve-like tissues from pluripotent stem cells with enhanced maturation recapitulate inflammatory valve disease. Cell Stem Cell. 2026-08-11. DOI: 10.1016/j.stem.2026.07.010

  3. University of Pittsburgh. Heart assembloids give researchers a new way to study heart valve disorders. 2026-08-11. https://www.pittwire.pitt.edu/features-articles/2026/08/11/heart-valve-organoid

  4. 科技日报. 类器官上首次培育出功能性心脏瓣膜,能模拟发育和病变过程. 2026-08-12. http://www.stdaily.com/web/gjxw/2026-08/11/content_562423.html

  5. Bioengineer.org. Heart assembloids offer new insights into heart valve disorders. 2026-08-11. https://bioengineer.org/heart-assembloids-offer-new-insights-into-heart-valve-disorders/


前往小宇宙评论区与主播互动